Clinical Trials Directory

Trials / Completed

CompletedNCT01748656

Target Volume in Noninvasive Positive Pressure Ventilation

Comparison of Two Noninvasive Positive Pressure Ventilation Devices Using Target Volume Modes in Obesity Hypoventilation Syndrome (OHS): A Pilot Randomized Crossover Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
AGIR à Dom · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients with OHS are efficiently managed with long term home-based nocturnal noninvasive positive pressure ventilation (NIPPV). Several NIPPV devices offer the feature of automatically adjusting pressure support (and/or respiratory back-up rate) on the basis of a pre-determined "ideal tidal volume" or "ideal ventilation". However algorithms used to achieve these ideal targets are different among different commercialized devices and the relative efficacy from an algorithm compared to another remains unknown. The main objective is this study is to compare two commercialized NIPPV that have this option

Detailed description

RESMED Stellar-150 (IVAPS mode)versus PHILIPS-RESPIRONICS A30 (AVAPS-mode).

Conditions

Interventions

TypeNameDescription
DEVICEIVAPSIVAPS mode (RESMED Stelar 150) during 1 night
DEVICEAVAPSAVAPS mode (PHILIPS-RESPIRONICS-A30) during 1 night

Timeline

Start date
2013-01-01
Primary completion
2013-09-01
Completion
2014-02-01
First posted
2012-12-12
Last updated
2014-03-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01748656. Inclusion in this directory is not an endorsement.